Cure My Disease

Don't miss your cure!

 Log in / Sign up

Inner ear implant aims to steady older adults with chronic dizziness

NCT ID NCT05676944

Recruiting now Disease control Sponsor: Johns Hopkins University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a vestibular implant in 15 older adults (ages 65-90) with chronic balance issues due to bilateral vestibular hypofunction. The implant electrically stimulates the inner ear to improve balance and vision. Researchers will measure changes in gait and eye reflexes over 6 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Labyrinth Devices MVI™ Multichannel Vestibular Implant System
What this could lead to
If successful, this could provide a new treatment option for older adults with chronic balance problems, improving their stability and quality of life.
What could go wrong
This is a small, early-stage study with only 15 participants, so results may not apply to everyone. The implant requires surgery and may have risks like infection or device failure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AMINOGLYCOSIDE OTOTOXICITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bilateral hypoactive labyrinth Bilateral Vestibulopathy cerebellar ataxia, intellectual disability, and dysequilibrium deafness, aminoglycoside-induced Dizziness idiopathic bilateral vestibulopathy inner ear disorder Ototoxicity Sensation Disorders vestibular disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AMINOGLYCOSIDE OTOTOXICITY BILATERAL VESTIBULAR DEFICIENCY (BVD) BILATERAL VESTIBULAR HYPOFUNCTION BILATERAL VESTIBULOPATHY GENTAMICIN OTOTOXICITY LABYRINTH DISEASES OTHER DISORDERS OF VESTIBULAR FUNCTION, BILATERAL PRESBYVESTIBULOPATHY SENSATION DISORDERS VESTIBULAR DISEASES

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Johns Hopkins School of Medicine

    RECRUITING

    Baltimore, Maryland, 21287, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.